[Phosphodiesterase inhibitors in clinical practice. The present and the future. Part II]. [electronic resource]
Producer: 20070726Description: 4-11 p. digitalISSN:- 0023-2149
- 3',5'-Cyclic-GMP Phosphodiesterases -- antagonists & inhibitors
- Bronchodilator Agents -- therapeutic use
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Drug Therapy -- trends
- Drug Therapy, Combination
- Forecasting
- Heart Failure -- drug therapy
- Humans
- Hypertension, Pulmonary -- drug therapy
- Iloprost -- therapeutic use
- Myocardial Infarction -- prevention & control
- Nitric Oxide -- therapeutic use
- Phosphodiesterase Inhibitors -- pharmacology
- Piperazines -- pharmacology
- Purines -- pharmacology
- Sildenafil Citrate
- Sulfones -- pharmacology
- Treatment Outcome
- Vasodilator Agents -- therapeutic use
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.